Skip to main content

Table 1 Age and pathological findings of cases of Paget’s disease of the nipple with underlying ductal carcinoma in situ

From: Role of GATA3 as a potential adjunct marker in the differential diagnosis of Paget’s disease of the nipple

Case

Age

Nuclear grade

ER Expression

PR Expression

HER2

1

70

High

Negative

Weak positive

Positive 3+

2

57

High

Negative

Weak positive

Positive 3+

3

37

High

Negative

Weak positive

Positive 3+

4

63

High

Negative

Negative

Negative

5

58

High

Negative

Negative

Positive 3+

6

57

High

Moderate 90%

Negative

Positive 3+

7

40

High

Negative

Weak positive

Positive 3+

8

74

High

Negative

Negative

Positive 3+

9

46

High

Strong 90%

Strong 90%

Negative

10

72

High

Negative

Negative

Positive3+

11

49

High

Negative

Negative

Positive 3+

12

56

High

NP

NP

NP

13

53

Intermediate

NP

NP

NP

14

39

Intermediate

Negative

Negative

Positive 3+

15

67

Intermediate

Negative

Negative

Positive 3+

16

60

Intermediate

Negative

Negative

Positive 3+

17

63

High

Negative

Negative

Negative

18

45

High

Negative

Negative

Positive 3+

19

33

High

Negative

Negative

Positive 3+

20

75

High

Negative

Negative

Positive 3+

21

64

High

Negative

Negative

Positive 3+

22

72

High

Negative

Negative

Positive 3+

  1. Legend: ER estrogen receptor; PR progesterone receptor; HER2 Human epidermal growth factor receptor, NP not performed